Melanie Thompson

20.3k citations

112 papers · 12.9k indexed · 12 hit papers · h-index 46

Impact in

Virology top 0.02%
- HIV Research and Treatment
Infectious Diseases top 0.02%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions

Papers in

Virology 70
- HIV Research and Treatment 70
Infectious Diseases 96
- HIV/AIDS drug development and treatment 82
- HIV/AIDS Research and Interventions 66

Co-authors: Donna M. Jacobsen Paul A. Volberding Douglas D. Richman Scott M. Hammer Margaret A. Fischl Michael S. Saag Robert T. Schooley Patrick Yéni
Journals: JAMA (16 papers)AIDS (15 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (9 papers)Clinical Infectious Diseases (5 papers)The Journal of Infectious Diseases (5 papers)
Partner nations: United States United Kingdom France

In The Last Decade

Melanie Thompson

109 papers receiving 12.5k citations

Hit Papers

12 papers align trajectories log scale

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults 2022 · 320 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 JAMA
2018 JAMA
2016 JAMA
2012 Annals of Internal Medicine
2012 JAMA
2010 JAMA
2008 JAMA
2006 JAMA
2004 JAMA
2002 JAMA
2000 JAMA
1998 JAMA

Peers

Countries citing papers authored by Melanie Thompson

Since Specialization

Citations

This map shows the geographic impact of Melanie Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melanie Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melanie Thompson more than expected).

Fields of papers citing papers by Melanie Thompson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melanie Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melanie Thompson. The network helps show where Melanie Thompson may publish in the future.

Co-authors

The 25 scholars most cited alongside Melanie Thompson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Melanie Thompson Line = papers co-authored together Melanie Thompson links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Statin Therapy as Primary Prevention for Persons With HIV: A Synopsis of Recommendations From the U.S. Department of Health and Human Services Antiretroviral Treatment Guidelines Panel Annals of Internal Medicine ·Craig J. Beavers, Alice K. Pau, David V. Glidden, Emily P. Hyle, Safia Kuriakose, Seth S. Martin, Grace A. McComsey, Melanie Thompson, Salim S. Virani, Jason V. Baker	2025	4
2	Ending the HIV Epidemic in Metropolitan Atlanta: a mixed‐methods study to support the local HIV/AIDS response Journal of the International AIDS Society ·Micah Piske, Bohdan Nosyk, Justin C. Smith, Bianca Yeung, Benjamin Enns, Xiao Zang, Patrick S. Sullivan, Wendy S. Armstrong, Melanie Thompson, Gaea Daniel, Carlos del Rı́o	2024	4
3	Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial The Lancet HIV ·David A. Wohl, Yazdan Yazdanpanah, Axel Baumgarten, Amanda Clarke, Melanie Thompson, Cynthia Brinson, Debbie Hagins, Moti Ramgopal, Andrea Antinori, Xuelian Wei, Rima Acosta, Sean E Collins, Diana M. Brainard, Hal Martin	2019	116
4	The first 90 Current Opinion in HIV and AIDS ·Melanie Thompson	2019	5
5	Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial The Lancet HIV ·Judith A. Aberg, Craig A. Sponseller, Douglas Ward, Vladimir A. Kryzhanovski, Stuart Campbell, Melanie Thompson	2017	61
6	Can, Want and Try: Parents’ Viewpoints Regarding the Participation of Their Child with an Acquired Brain Injury PLoS ONE ·Melanie Thompson, Catherine Elliott, Claire Willis, Roslyn Ward, Marita Falkmer, Torbjörn Falkmer, Anna Gubbay, Sonya Girdler	2016	15
7	A 48-week randomized phase 2b study evaluating cenicriviroc versus efavirenz in treatment-naive HIV-infected adults with C-C chemokine receptor type 5-tropic virus AIDS ·Melanie Thompson, Michael S. Saag, Edwin DeJesus, Joseph Gathe, Jay Lalezari, Alan Landay, Jerry Cade, Jeffrey Enejosa, Éric Lefebvre, Judith Feinberg	2015	67
8	Elicitation of Immune Responses by a DNA/MVA Vaccine in ART Treated Patients in a Treatment Interruption Trial AIDS Research and Human Retroviruses ·Harriet L. Robinson, Melanie Thompson, Sonya L. Heath, Stephen J. Brown, Bentley Sweeton, Kathy Williams, Pamela Cunningham, Miles Viljanen, Rahul Basu, Yongxian Xu, Suefen Kwa	2014	1
9	Forty‐eight‐week efficacy and safety and early CNS tolerability of doravirine (MK‐1439), a novel NNRTI, with TDF/FTC in ART‐naive HIV‐positive patients Journal of the International AIDS Society ·Josep M. Gatell, Javier O Morales‐Ramirez, Debbie Hagins, Melanie Thompson, Keikawus Arastéh, Christian Hoffmann, Sorin Rugină, Olayemi Osiyemi, Simona Escoriu, Robin Dretler, Charlotte Harvey, Xia Xu, Hedy Teppler	2014	45
10	Safety, Tolerability, and Efficacy of Raltegravir in a Diverse Cohort of HIV-Infected Patients: 48-Week Results from the REALMRK Study AIDS Research and Human Retroviruses ·Kathleen Squires, Linda‐Gail Bekker, Joseph J. Eron, Hon Wai Benjamin Cheng, Juergen Rockstroh, Farid Marquez, Princy Kumar, Melanie Thompson, Rafael Campo, Karam Mounzer, Kim M. Strohmaier, Chengxing Lu, Anthony Rodgers, Beth E. Jackson, Larissa Wenning, Michael Robertson, Bach-Yen Nguyen, for the REALMRK Investigator Peter Sklar	2013	16
11	Antiretroviral Treatment of Adult HIV Infection JAMA ·Melanie Thompson, (unknown), (unknown), (unknown), (unknown), Pedro Cahn, Joseph J. Eron, Margaret A. Fischl, Scott M. Hammer, Peter Reiss, Douglas D. Richman, (unknown), (unknown), Donna M. Jacobsen, Paul A. Volberding Hit paper breakdown →	2012	1364
12	Bone Mineral Density in HIV-Negative Men Participating in a Tenofovir Pre-Exposure Prophylaxis Randomized Clinical Trial in San Francisco PLoS ONE ·Albert Liu, Eric Vittinghoff, Deborah E. Sellmeyer, Risha Irvin, Kathleen Mulligan, Kenneth H. Mayer, Melanie Thompson, Robert M. Grant, Sonal Pathak, Brandon O’Hara, Roman Gvetadze, Kata Chillag, Lisa A. Grohskopf, Susan Buchbinder	2011	126
13	Improved Prevention Counseling by HIV Care Providers in a Multisite, Clinic-Based Intervention: Positive STEPs AIDS Education and Prevention ·Mark Thrun, Paul Cook, Lucy Bradley‐Springer, Lytt I. Gardner, Gary Marks, Julie Wright, Tracey E. Wilson, E. Byrd Quinlivan, Christine O’Daniels, Stephen Raffanti, Melanie Thompson, Carol E. Golin	2009	23
14	Seven-Year Efficacy of a Lopinavir/Ritonavir-Based Regimen in Antiretroviral—Naïve HIV-1-Infected Patients HIV Clinical Trials ·Robert L. Murphy, Barbara A. da Silva, Charles B. Hicks, Joseph J. Eron, Roy M. Gulick, Melanie Thompson, F McMillan, Martin King, George J. Hanna, Scott C. Brun	2008	52
15	Antiretroviral Treatment of Adult HIV Infection JAMA ·Scott M. Hammer, Joseph J. Eron, Peter Reiss, Robert T. Schooley, Melanie Thompson, Sharon Walmsley, Pedro Cahn, Margaret A. Fischl, José M. Gatell, Martin Hirsch, Donna M. Jacobsen, Joan Montaner, Douglas D. Richman, Patrick Yéni, Paul A. Volberding Hit paper breakdown →	2008	832
16	Twice‐Daily Trizivir versus Combivir‐Abacavir in Antiretroviral‐Experienced Adults with Human Immunodeficiency Virus‐1 Infection: A Formulation‐Switch Trial Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·(unknown), Margaret A. Fischl, Alfred F. Burnside, Charles Farthing, Melanie Thompson, Nicholaos Bellos, Vanessa C. Williams, Teresa L. Kauf, Paul Wannamaker, Mark S. Shaefer	2003	1
17	Once‐Daily Quadruple‐Drug Therapy with Adefovir Dipivoxil, Lamivudine, Didanosine, and Efavirenz in Treatment‐Naive Human Immunodeficiency Virus Type 1–Infected Patients The Journal of Infectious Diseases ·Gail Skowron, Daniel R. Kuritzkes, Melanie Thompson, Kathleen Squires, Shirley Goodwin, Betsy A. Dusak, Jerry M. Tolson, M. L. Stevens, Geoffrey J. Yuen, James F. Rooney	2002	10
18	Antiretroviral Therapy in Adults JAMA ·Charles C. J. Carpenter, David A. Cooper, Margaret A. Fischl, José M. Gatell, Brian Gazzard, Scott M. Hammer, Martin Hirsch, Donna M. Jacobsen, David Katzenstein, Joan Montaner, Douglas D. Richman, Michael S. Saag, Mauro Schechter, Robert T. Schooley, Melanie Thompson, Stefano Vella, Patrick Yéni, Paul A. Volberding Hit paper breakdown →	2000	874
19	A retrospective study to determine if hydroxyurea augmentation of antiretroviral drug regimens that contain ddI and/or d4T increases the risk of developing peripheral neuropathy in HIV-1 infected individuals Pharmacoepidemiology and Drug Safety ·William F. McCarthy, Julia Gable, John Lawrence, Melanie Thompson	2000	9
20	Effect of clinical events on plasma HIV-1 RNA levels in persons with CD4+ T-lymphocyte counts of more than 500 ×106 cells/l AIDS ·Louisa E. Chapman, Timothy A. Green, Farhad Ahmed, Bharat Parekh, David Rimland, Jonathan E. Kaplan, Melanie Thompson, Thomas M. Folks	2000	2

About Melanie Thompson

Melanie Thompson is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Hepatology and Epidemiology, having authored 112 papers that have together received 12.9k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (82 papers), HIV Research and Treatment (70 papers), HIV/AIDS Research and Interventions (66 papers), HIV-related health complications and treatments (33 papers), HIV, Drug Use, Sexual Risk (8 papers), Pneumocystis jirovecii pneumonia detection and treatment (7 papers), Lipoproteins and Cardiovascular Health (6 papers) and Adolescent Sexual and Reproductive Health (5 papers). The work is most often cited by research in Virology (7.4k citations), Infectious Diseases (10.4k citations), Emergency Medicine (2.5k citations), Hepatology (891 citations) and Epidemiology (3.6k citations). Melanie Thompson has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Donna M. Jacobsen, Paul A. Volberding, Douglas D. Richman, Scott M. Hammer, Margaret A. Fischl, Michael S. Saag, Robert T. Schooley, Patrick Yéni, Martin Hirsch and Joseph J. Eron. Their work appears in journals such as JAMA, AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes, Clinical Infectious Diseases and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact